B-MYB transactivates its own promoter through SP1-binding sites

被引:42
作者
Sala, A
Saitta, B
De Luca, P
Cervellera, MN
Casella, I
Lewis, RE
Watson, R
Peschle, C
机构
[1] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Mol Pharmacol & Pathol, I-66030 Santa Maria Imbaro, CH, Italy
[2] Thomas Jefferson Univ, Kimmel Canc Inst, Dept Immunol Microbiol, Philadelphia, PA 19107 USA
[3] Dept Reumatol, Philadelphia, PA 19107 USA
[4] Univ Naples Federico II, Dept Genet Mol & Gen Biol, I-80134 Naples, Italy
[5] Univ Nebraska, Med Ctr, Eppley Canc Inst, Omaha, NE 68198 USA
[6] St Marys Hosp, Sch Med, Ludwig Inst Canc Res, London W2 1PG, England
[7] Ist Super Sanita, Lab Ematol Oncol, I-00161 Rome, Italy
关键词
B-MYB; cell-cycle; promoter; SP1; transcription;
D O I
10.1038/sj.onc.1202421
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
B-MYB is an ubiquitous protein required for mammalian cell growth. In this report we show that B-MYB transactivates its own promoter through a 120 bp segment proximal to the transcription start site. The B-MYB-responsive element does not contain myb-binding sites and gel-shift analysis shows that SP1, but not B-MYB, protein contained in SAOS2 cell extracts binds to the 120 bp B-myb promoter fragment. B-MYB-dependent transactivation is cooperatively increased in the presence of SP1, but not SP3 overexpression, When the SP1 elements of the B-myb promoter are transferred in front of a heterologous promoter, an increased response to B-MYB results. In contrast, c-MYB, the prototype member of the Myb family, is not able to activate the luciferase construct containing the SP1 elements. With the use of an SP1-GAL4 fusion protein, we have determined that the cooperative activation occurs through the domain A of SP1, These observations suggest that B-MYB functions as a coactivator of SP1, and that diverse combinations of myb and SP1 sites may dictate the responsiveness of myb-target genes to the various members of the myb family.
引用
收藏
页码:1333 / 1339
页数:7
相关论文
共 38 条
[1]  
ARSURA M, 1992, BLOOD, V79, P2708
[2]  
Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229
[4]  
BIES J, 1995, CANCER RES, V55, P501
[5]  
Bies J, 1996, ONCOGENE, V12, P355
[6]   TRANSCRIPTIONAL INITIATION IS CONTROLLED BY UPSTREAM GC-BOX INTERACTIONS IN A TATAA-LESS PROMOTER [J].
BLAKE, MC ;
JAMBOU, RC ;
SWICK, AG ;
KAHN, JW ;
AZIZKHAN, JC .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (12) :6632-6641
[7]   CONSTITUTIVE EXPRESSION OF A C-MYB CDNA BLOCKS FRIEND MURINE ERYTHROLEUKEMIA CELL-DIFFERENTIATION [J].
CLARKE, MF ;
KUKOWSKALATALLO, JF ;
WESTIN, E ;
SMITH, M ;
PROCHOWNIK, EV .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) :884-892
[8]   Sp3 represses transcription when tethered to promoter DNA or targeted to promoter proximal RNA [J].
DeLuca, P ;
Majello, B ;
Lania, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) :8533-8536
[9]   An inhibitor domain in Sp3 regulates its glutamine-rich activation domains [J].
Dennig, J ;
Beato, M ;
Suske, G .
EMBO JOURNAL, 1996, 15 (20) :5659-5667
[10]   WEAK TRANSCRIPTIONAL ACTIVATION IS SUFFICIENT FOR TRANSFORMATION BY V-MYB [J].
ENGELKE, U ;
WHITTAKER, L ;
LIPSICK, JS .
VIROLOGY, 1995, 208 (02) :467-477